blue and white bottles of Monsantos Roundup herbicide on a store shelf

Glyphosate Industry Fails to Stop US Funding for Global Cancer Agency

In a massive victory for independent science, it was announced Sunday that the U.S. Senate and Congress appropriations committees have deleted text from a controversial Bill, which would have cut all the U.S. funding to the International Agency for Research on Cancer (IARC), after they challenged the chemical industry by classifying the world’s most used herbicide, glyphosate, as a probable human carcinogen in 2015.

September 16, 2018 | Source: Sustainable Pulse | by

In a massive victory for independent science, it was announced Sunday that the U.S. Senate and Congress appropriations committees have deleted text from a controversial Bill, which would have cut all the U.S. funding to the International Agency for Research on Cancer (IARC), after they challenged the chemical industry by classifying the world’s most used herbicide, glyphosate, as a probable human carcinogen in 2015.

The ‘IARC rider’ text on page 110 (sec.229) of the draft Labor Health and Human Services FY19 Appropriations Bill was removed after negotiations.

Currently, 25 Nations contribute to IARC’s total budget of about USD $50 million (about EUR 44 million), with 7.5% (USD $3.8 million) coming from the U.S..

Following IARC’s classification of glyphosate as a probable human carcinogen in 2015, Monsanto and the American Chemistry Council launched a full-throttle attack on the international scientific body.

So why all the fuss about IARC and its glyphosate review?

IARC is an arm of the World Health Organization and funded by 24 governments, and predominantly by the NIH National Cancer Institute.